MetLife Investment Management, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2021$118,668
+28.1%
43,789
+110.9%
0.00%0.0%
Q3 2021$92,612
-58.6%
20,765
-46.2%
0.00%
-50.0%
Q2 2021$223,752
+150.0%
38,578
+202.5%
0.00%
+100.0%
Q1 2021$89,512
-50.4%
12,751
-66.1%
0.00%
-50.0%
Q4 2020$180,629
-8.8%
37,631
+10.8%
0.00%0.0%
Q3 2020$198,080
-13.6%
33,9760.0%0.00%
-33.3%
Q2 2020$229,338
+64.2%
33,976
+54.7%
0.00%
+50.0%
Q1 2020$139,710
-39.0%
21,9670.0%0.00%0.0%
Q4 2019$229,006
+165.3%
21,9670.0%0.00%
+100.0%
Q3 2019$86,330
-73.6%
21,9670.0%0.00%
-75.0%
Q2 2019$326,649
-40.1%
21,9670.0%0.00%
-33.3%
Q1 2019$545,221
+38.2%
21,9670.0%0.01%
+20.0%
Q4 2018$394,527
-38.8%
21,9670.0%0.01%
-28.6%
Q3 2018$645,171
-35.4%
21,9670.0%0.01%
-41.7%
Q2 2018$999,000
-6.4%
21,967
+8.7%
0.01%
-7.7%
Q1 2018$1,067,000
-22.3%
20,2030.0%0.01%
-18.8%
Q4 2017$1,374,00020,2030.02%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,402,781$231,389,0009.96%
Versant Venture Management, LLC 101,855$6,926,140,0007.29%
Avoro Capital Advisors LLC 1,102,884$74,996,0004.86%
Redmile Group, LLC 1,320,027$89,762,0003.90%
NEXTHERA CAPITAL LP 233,200$15,858,0002.92%
Iguana Healthcare Management, LLC 60,000$4,080,0002.66%
HealthCor Management, L.P. 973,840$66,221,0002.16%
Casdin Capital, LLC 127,500$8,670,0002.11%
Prosight Management, LP 40,000$2,720,0002.00%
Camber Capital Management LP 600,000$40,800,0002.00%
View complete list of CLOVIS ONCOLOGY INC shareholders